This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by D'Cruz, O. J. Articles by Uckun, F. M. Search for Related Content PubMed PubMed Citation Articles by D'Cruz, O. J. Articles by Uckun, F. M. Social Bookmarking                         What's this?

Mucosal Toxicity Studies of a Gel Formulation of Native Pokeweed Antiviral Protein

Drug Discovery Program, Department of Reproductive Biology, Paradigm Pharmaceuticals, LLC 2685 Patton Road, St. Paul, Minnesota 55113, USA, odcruz{at}ih.org

Barbara Waurzyniak

Experimental Pathology, Paradigm Pharmaceuticals, LLC 2685 Patton Road, St. Paul, Minnesota 55113, USA

Fatih M. Uckun

Virology, Parker Hughes Institute, 2657 Patton Road, St. Paul, Minnesota 55113, USA

Pokeweed antiviral protein (PAP), a 29-kDa plant-derived protein isolated from Phytolacca americana, is a promising nonspermicidal broad-spectrum antiviral microbicide. This study evaluated the mucosal toxicity potential of native PAP in the in vivo rabbit vaginal irritation model as well as the in vitro reconstituted human vaginal epithelial tissue model. Twenty-two New Zealand white rabbits in 4 subgroups were exposed intravaginally to a gel with and without 0.01, 0.1, or 1.0% native PAP for 10 consecutive days. The dose of PAP used represented nearly 200- to 20,000 times its in vitro anti-HIV IC50 value. Animals were euthanized on day 11 and vaginal tissues were evaluated for histologic and immunohistochemical evidence of mucosal toxicity, cellular inflammation, and hyperplasia. Blood was analyzed for changes in hematology and clinical chemistry profiles. Reconstituted human vaginal epithelial tissue grown on membrane filters was exposed to 0.1, 0.1, or 1.0% native PAP in medium or topically via a gel for 24 hours and tissue damage was evaluated by histological assessment. In the in vivo rabbit vaginal irritation model, half of all PAP-treated rabbits (8/16) exhibited an acceptable range of vaginal mucosal irritation (total score <8 out of a possible 16), whereas nearly a third of PAP-treated rabbits (5/16) developed moderate to marked vaginal mucosal irritation (total score >11). However, no treatment-related adverse effects were seen in hematological or clinical chemistry measurements. Furthermore, in vitro exposure of a 3-dimensional human vaginal tissue grown on polycarbonate membrane filters to identical concentrations of PAP either added to culture medium or applied topically via gel formulation did not result in direct toxicity as determined by histologic evaluation. These findings indicate careful monitoring of vaginal irritation will be required in the clinical development of PAP as a nonspermicidal microbicide.

Key Words: Antiviral protein • HIV/AIDS • intravaginal • microbicide • ribosome inactivating protein.

Toxicologic Pathology, Vol. 32, No. 2, 212-221 (2004)
DOI: 10.1080/01926230490274362


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?